Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B

被引：0
|
作者：
Benoit Guillet
Songkai Yan
Becky Hooper
Douglass Drelich
Jason Steenkamp
Radovan Tomic
Maria Elisa Mancuso
机构：
[1] Hemophilia Treatment Center of Rennes-Bretagne,
[2] University Hospital Center (CHU) Rennes,undefined
[3] CSL Behring,undefined
[4] EVERSANA,undefined
[5] CSL Behring,undefined
[6] IRCCS Humanitas Research Hospital and Humanitas University,undefined
来源：
Advances in Therapy | 2024年 / 41卷
关键词：
Efficacy; Hemophilia B; Matching-adjusted indirect comparisons; Prophylactic treatment; Recombinant factor IX albumin fusion protein; Recombinant factor IX Fc fusion protein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：649 / 658
页数：9
相关论文
共 50 条
  • [1] Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B
    Guillet, Benoit
    Yan, Songkai
    Hooper, Becky
    Drelich, Douglass
    Steenkamp, Jason
    Tomic, Radovan
    Mancuso, Maria Elisa
    ADVANCES IN THERAPY, 2024, 41 (02) : 649 - 658
  • [2] Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice
    van der Flier, Arjan
    Hong, Vu
    Liu, Zhan
    Piepenhagen, Peter
    Ulinski, Gregory
    Dumont, Jennifer A.
    Orcutt, Kelly D.
    Goel, Apollina
    Peters, Robert
    Salas, Joe
    BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 (06) : 353 - 363
  • [3] Recombinant factor IX Fc for the treatment of hemophilia B
    Ljung, Rolf
    Matino, Davide
    Shapiro, Amy D.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (05) : 678 - 691
  • [4] Continuous prophylaxis with recombinant factor IX Fc fusion protein and conventional recombinant factor IX products: comparisons of efficacy and weekly factor consumption
    Iorio, Alfonso
    Krishnan, Sangeeta
    Myren, Karl-Johan
    Lethagen, Stefan
    McCormick, Nora
    Yermakov, Sander
    Karner, Paul
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (04) : 337 - 344
  • [5] Cost-effectiveness analysis of recombinant factor IX Fc fusion protein compared with recombinant factor IX for the treatment of moderate-severe to severe hemophilia B in China
    Zhou, Ting
    Wang, Shuyue
    Zhang, Yao
    Wu, Runhui
    Li, Hongchao
    PEDIATRIC BLOOD & CANCER, 2023, 70 (06)
  • [6] Transforming the treatment for hemophilia B patients: update on the clinical development of recombinant fusion protein linking recombinant coagulation factor IX with recombinant albumin (rIX-FP)
    Santagostino, Elena
    THROMBOSIS RESEARCH, 2016, 141 : 5 - 8
  • [7] Alprolix (recombinant Factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B
    Ducore, Jonathan M.
    Miguelino, Maricel G.
    Powell, Jerry S.
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (05) : 559 - 571
  • [8] Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX-Fc fusion protein: A randomized trial
    Ettingshausen, Carmen Escuriola
    Hegemann, Inga
    Simpson, Mindy L.
    Cuker, Adam
    Kulkarni, Roshni
    Pruthi, Rajiv K.
    Garly, May-Lill
    Meldgaard, Rikke M.
    Persson, Paula
    Klamroth, Robert
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (02) : 268 - 276
  • [9] Extending recombinant factor IX Fc fusion protein dosing interval to 14 or more days in patients with hemophilia B
    Shapiro, Amy D.
    Pasi, K. John
    Ozelo, Margareth C.
    Kulkarni, Roshni
    Barnowski, Christopher
    Winding, Bent
    Szamosi, Johan
    Lethagen, Stefan
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (01) : 109 - 113
  • [10] Population pharmacokinetics of a new long-acting recombinant coagulation factor IX albumin fusion protein for patients with severe hemophilia B
    Zhang, Y.
    Roberts, J.
    Bensen-Kennedy, D.
    Jacobs, I.
    Santagostino, E.
    Voigt, C.
    Feussner, A.
    Morfini, M.
    Sidhu, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (11) : 2132 - 2140
12345